Skip to main content
. 2023 Sep 16;17(1):116. doi: 10.1186/s13065-023-01003-3

Table 8.

ADMET Results of the test with SwissADME for the target compounds 7k, 7l, 7m, and Erlotinib

Compound M.Wt Fraction Csp3 RB HBA HBD MR TPSA Log P GI absorption BBB perm. Lip. V. Bio. Sc.
7k 587.65 0.06 11 7 2 166.67 148.30 3.28 Low No Yes 0.55
7l 622.09 0.06 11 7 2 171.68 148.30 5.87 Low No No 0.17
7m 617.67 0.09 12 8 2 173.17 157.53 5.41 Low No Yes 0.55
Erlotinib 393.44 0.27 10 6 1 111.40 74.73 3.28 High Yes Yes 0.55